Dr. David R. Friedland, MD, PhD

Dr. Friedland practices at Keck Medicine of USC - USC Roski Eye Institute - Ophthalmology - HOPD in Los Angeles, California.

Dr. Friedland's NPI, 1760433148, was assigned on May 12, 2006. Dr. Friedland graduated from Icahn School Of Medicine At Mount Sinai in 1995. Dr. Friedland's Wisconsin license number on file is 44333.

Dr. Friedland's primary practice is Keck Medicine of USC - USC Roski Eye Institute - Ophthalmology - HOPD, at 1450 San Pablo St, Los Angeles, CA 90033.

Dr. Friedland's primary practice is Keck Medicine of USC - USC Roski Eye Institute - Ophthalmology - HOPD in Los Angeles, California. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Friedland to 1 more group practice or clinic and 1 medical group, each named with a free account. Dr. Friedland's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Friedland practices, 2 sites in all. Vendor and product names are available with a free account.

Otology and neurotology is Dr. Friedland's primary specialty in the NPI Registry, under taxonomy code 207YX0901X. Dr. Friedland is board certified in neurotology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Friedland's licenses on file in 3 states: Wisconsin, California and Maryland.

Dmand AI lists ear eustachian tube disorders, hearing loss and impairment, tinnitus and vertigo among the conditions Dr. Friedland treats.

CMS data shows 71 Medicare services from Dr. Friedland across 5 procedure codes in 2024, for 68 Medicare patients. Medicare paid $14,049 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 68 Medicare patients who saw Dr. Friedland in 2024. The largest group is 65 to 74, with 30 patients. 65% of them have high cholesterol, and 51% have high blood pressure. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Friedland's median patient age at 65, with 57% women.

In 2024, Dr. Friedland wrote 34 Medicare Part D claims for 16 patients. 94% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $506 in total drug cost. In 2021, CMS named 49 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Friedland for performance year 2024, reported as part of a group. Dr. Friedland accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 87 papers to Dr. Friedland, published from 2005 to 2025. 2022 was the busiest year, with 7. The most frequent topics are Cochlear Implants, Cochlear Implantation and Hearing Loss, Sensorineural. Dr. Friedland has published most often in Otol Neurotol. Dr. Friedland's most frequent co-authors are Joseph E. Kerschner, MD, David M. Poetker, MD and Joel H. Blumin, MD.

CMS Open Payments shows 35 general payments to Dr. Friedland from 4 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 32% of the total. MED-EL Corporation paid the most, $14,259.

Dmand AI lists 2 awards for Dr. Friedland.

Dr. Friedland graduated from Icahn School Of Medicine At Mount Sinai in 1995. Dr. Friedland is a member of NHS, American Neurotology Society, American Otological Society and Triological Society.

Dr. Friedland is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.